Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis-Reference-Cited by-同舟云学术

Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis

Published:2018-01-25 Issue:1 Volume:13 Page:e0189294
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Li Ziyu,Shan Fei,Wang Yinkui^ORCID,Zhang Yan,Zhang Lianhai,Li Shuangxi,Jia Yongning,Xue Kan,Miao Rulin,Li Zhemin,Ji Jiafu

Funder

Beijing Municipal Science and Technology Commission

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. NCCN Guidelines Version 1.2015 Staging Gastric Cancer. 2015.

2. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;D Cunningham;The New England journal of medicine,2006

3. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial;M Ychou;Journal of clinical oncology: official journal of the American Society of Clinical Oncology,2011

4. Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials;G von Minckwitz;Breast Cancer Res Treat,2011

5. Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy;N Houssami;Eur J Cancer,2012

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced Gastric Cancer: CT Radiomics Prediction of Lymph Modes Metastasis After Neoadjuvant Chemotherapy;Journal of Imaging Informatics in Medicine;2024-06-17

2. Impact of pCR after neoadjuvant chemotherapy and radical D2 dissection in locally advanced gastric cancers: Analysis of 1001 cases;European Journal of Surgical Oncology;2024-06

3. Efficacy evaluation and survival analysis of the combination of oxaliplatin plus Teysuno (SOX) with immune checkpoint inhibitors in the conversion therapy of locally advanced gastric cancer;Oncology and Translational Medicine;2024-05-01

4. Safety and efficacy of a programmed cell death 1 inhibitor combined with oxaliplatin plus S-1 in patients with Borrmann large type III and IV gastric cancers;World Journal of Gastrointestinal Oncology;2024-04-15

5. Current status of neoadjuvant immunotherapy for the treatment of gastric cancer;Clinical and Translational Oncology;2024-03-20